Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

roche_dark_0

Roche’s Tecentriq+chemo boosts survival in first-line non-small cell lung cancer

October 22, 2018 Research and Development, Sales and Marketing Cancer, Roche, lung cancer NSCLC, pharma, tecentriq

Roche joined other major players like Bristol-Myers Squibb in revealing strong data on their cancer immunotherapies at the European Society …
News

Working Life: Joe Wiley, CEO, Amryt Pharma

October 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …
Feature

Takeda’s subcutaneous vedolizumab proves efficacious in Phase III trial for Ulcerative Colitis

October 22, 2018 Sales and Marketing Takeda, UC, biologic, phase III, results, ulcerative colitis, vedolizumab

Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved efficacious …
News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya maintains skin clearance after 3 years in plaque psoriasis

October 22, 2018 Research and Development, Sales and Marketing Janssen, Tremfya, pharma, plaque psoriasis, psoriasis

Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin …
News

BMS’ Opdivo and Yervoy combination shows outstanding survival rate in cancer patients

October 22, 2018 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Yervoy, melanoma, opdivo

American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with …
News

GSK named third best UK workplace

October 22, 2018 Sales and Marketing AbbVie, Amgen, BMS, Eli Lilly, GSK, J&J, JJ, work

British multinational GlaxoSmithKline has been rated as the third best company to work for in the UK, according to jobs …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
News
lilly_entrance_web

NICE rejects Elil Lilly’s Verzenio for breast cancer in draft guidance

October 19, 2018 Medical Communications, Sales and Marketing Eli Lilly, NICE, UK, Verzenios, breast cancer, pharma

Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …
News
causes_of_hearing_lose_jpg

Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?

October 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
Feature
novartis_window

Novartis snaps up cancer drug developer Endocyte for $2.1 billion

October 18, 2018 Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma

Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
News
310px-pharmacie_in_paulista_avenue

MHRA to extend EpiPen expiry dates to tackle shortages

October 18, 2018 Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen

The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
News

Pfizer announce cull of 2% of staff

October 18, 2018 Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs

US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …
News

Samsung and Bioepis launch third Humira biosimilar in Europe

October 17, 2018 Research and Development, Sales and Marketing Amgen, Biogen, Humira, Imraldi, Samusng Bioepis, pharma

Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of …
News

FDA approves Pfizer’s Talzenna for breast cancer alongside tool to identify eligible patients

October 17, 2018 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, Talzenna, breast cancer, pharma

Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
News
roche

Roche’s Kadcyla beats Herceptin breast cancer disease recurrence and death risk

October 16, 2018 Manufacturing and Production, Sales and Marketing Cancer, Kadcyla, Roche, breast cancer, pharma

Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025